Congrats to Chilkoti Group and Cohorts (Dewhirst and Zalutsky) as they have recently secured 2 new R01 grants: one to combat tumors with engineered thermally responsive multivalency and another to improve the delivery of drugs in general using the unique properties elastin-esque biopolymers.
